In after-hours trading, several companies have made notable headlines due to their recent earnings reports and other significant developments.
Ulta Beauty experienced an 8% drop in its shares following the release of its fourth-quarter earnings, which did not meet analyst expectations. The beauty products retailer reported earnings of $8.01 per share, falling slightly short of the anticipated $8.03 per share. However, its revenue of $3.90 billion exceeded expectations, which had been set at $3.80 billion.
Meanwhile, shares of Adobe slid nearly 7% as CEO Shantanu Narayen announced his plans to step down after a successor is appointed. Despite the leadership change, which overshadowed the company’s strong first-quarter results, Narayen will remain as chair of the board. He has held the CEO position since 2007.
Lennar, a prominent homebuilder, saw its stock drop 2% after reporting a second consecutive quarterly earnings miss. The company announced earnings of 93 cents per share, falling short of the expected 96 cents, accompanied by revenue of $6.62 billion, which also did not meet analyst projections of $6.88 billion.
In contrast, Rubrik, a data security and cloud company, enjoyed a 2% increase in its stock price, thanks to its fourth-quarter adjusted earnings of 4 cents per share, surprising analysts who had anticipated a loss of 11 cents. Revenue for Rubrik came in at $378 million, surpassing expectations of $342 million. The company also provided an optimistic outlook for its first-quarter revenue, projecting figures between $365 million and $367 million, ahead of the consensus forecast of $351 million.
On the downside, shares of Sentinel One, a cybersecurity firm, declined nearly 3% after it issued a cautious outlook for its first-quarter adjusted earnings. The company expects earnings in the range of 1 to 2 cents per share, missing the consensus estimate of 5 cents. While SentinelOne narrowly exceeded earnings estimates for the fourth quarter, its revenue of $271 million aligned with expectations.
Finally, Insulet, known for its continuous glucose monitoring devices, announced a recall of certain batches of its Omnipod 5 pods. The recall is due to a small tear in the internal tubing, which could lead to inadequate insulin delivery to patients. Although several users have been hospitalized, no fatalities have been reported. Insulet emphasized that the issue is confined to specific lots, and other versions of its Omnipod 5 products remain safe for user consumption. Following this news, Insulet’s shares fell by 7%.
